DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Letairis (Ambrisentan) - Blood Urea Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Blood Urea Increased ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Letairis (Ambrisentan) where reactions include blood urea increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Letairis side effects in female

Reported by a physician from United States on 2012-03-01

Patient: female

Reactions: Unresponsive To Stimuli, Tachycardia, Blood PH Decreased, Prothrombin Time Prolonged, PO2 Decreased, Haematocrit Decreased, Cardio-Respiratory Arrest, Blood Pressure Immeasurable, Blood Creatinine Increased, Blood Sodium Decreased, White Blood Cell Count Increased, Oxygen Saturation Decreased, Blood Glucose Increased, Blood Urea Increased, Pneumonia, International Normalised Ratio Increased, Blood Bicarbonate Decreased, Haemoglobin Decreased, Sepsis, Aspartate Aminotransferase Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
70 / 30 MIX

Letairis
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2010-03-10
    End date: 2012-02-16

Other drugs received by patient: Levothyroxine Sodium; Humalog; Potassium Chloride; Lasix; Adcirca; Oxygen; Ocuvite / 01053801 /; Atenolol; Coumadin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012